Skip to main content
Erschienen in: Journal of Gastroenterology 2/2010

01.02.2010 | Original Article—Alimentary Tract

Predictors of a better outcome of pneumatic dilatation in patients with primary achalasia

verfasst von: Yuriko Tanaka, Katsuhiko Iwakiri, Noriyuki Kawami, Hirohito Sano, Mariko Umezawa, Makoto Kotoyori, Yoshio Hoshihara, Tsutomu Nomura, Masao Miyashita, Choitsu Sakamoto

Erschienen in: Journal of Gastroenterology | Ausgabe 2/2010

Einloggen, um Zugang zu erhalten

Abstract

Objective

Pneumatic dilatation (PD) has been widely used in the treatment of primary achalasia. The aim of this study was to evaluate the effectiveness of PD and its predictive factors in Japanese patients with primary achalasia.

Methods

Fifty-five consecutive patients were treated using PD (Rigiflex balloon dilator). Diagnosis was established through radiographic and/or esophageal manometry. All patients underwent a pre-designed clinical evaluation prior to and 6 months after PD treatment. We defined success of PD as 6 months or more of clinical remission, with a total score (0–4) ≤2, a decrease in the total score ≥1 and the score for each item ≤1. Possible predictive factors to response were analyzed.

Results

Successful PD was achieved in 41 of 55 (74.5%) patients. The median age (58.0 years) in the successful group was significantly older than in the failure group (37.5 years), but there were no differences in other factors between the groups. When the cut-off value was set at 40 years of age, the success rate of PD in the >40-year age group was 85.7%, while the <40-year age group achieved a rate of only 38.5%. Multivariate logistic regression analysis also demonstrated that older age was the only independent factor associated with the success of PD. There was no perforation related to PD.

Conclusions

PD is a safe and effective treatment for achalasia, particularly in older patients who experience a better outcome than younger patients.
Literatur
1.
Zurück zum Zitat Cohen S. Motor disorders of the esophagus. N Engl J Med. 1979;26(301):184–92.CrossRef Cohen S. Motor disorders of the esophagus. N Engl J Med. 1979;26(301):184–92.CrossRef
2.
Zurück zum Zitat Vantrappen G, Hellemans J. Treatment of achalasia and related motor disorders. Gastroenterology. 1980;79:144–54.PubMed Vantrappen G, Hellemans J. Treatment of achalasia and related motor disorders. Gastroenterology. 1980;79:144–54.PubMed
3.
Zurück zum Zitat Vaezi MF, Richter JE. Current therapies for achalasia. J Clin Gastroenterol. 1998;27:21–35.CrossRefPubMed Vaezi MF, Richter JE. Current therapies for achalasia. J Clin Gastroenterol. 1998;27:21–35.CrossRefPubMed
4.
Zurück zum Zitat Birgisson S, Richter JE. Achalasia: what’s new in diagnosis and treatment? Dig Dis. 1997;15(Suppl 1):1–27.CrossRefPubMed Birgisson S, Richter JE. Achalasia: what’s new in diagnosis and treatment? Dig Dis. 1997;15(Suppl 1):1–27.CrossRefPubMed
5.
Zurück zum Zitat Vantrappen G, Janssens J. To dilate or to operate? That is the question. Gut. 1983;24:1013–9.CrossRefPubMed Vantrappen G, Janssens J. To dilate or to operate? That is the question. Gut. 1983;24:1013–9.CrossRefPubMed
6.
Zurück zum Zitat Staiano A, Clouse RE. Detection of incomplete lower esophageal sphincter relaxation with conventional point-pressure sensors. Am J Gastroenterol. 2001;96:3258–67.CrossRefPubMed Staiano A, Clouse RE. Detection of incomplete lower esophageal sphincter relaxation with conventional point-pressure sensors. Am J Gastroenterol. 2001;96:3258–67.CrossRefPubMed
7.
Zurück zum Zitat Wehrmann T, Jacobi V, Jung M, Lembcke B, Caspary WF. Pneumatic dilation in achalasia with a low-compliance balloon: results of a 5-year prospective evaluation. Gastrointest Endosc. 1995;42:31–6.CrossRefPubMed Wehrmann T, Jacobi V, Jung M, Lembcke B, Caspary WF. Pneumatic dilation in achalasia with a low-compliance balloon: results of a 5-year prospective evaluation. Gastrointest Endosc. 1995;42:31–6.CrossRefPubMed
8.
Zurück zum Zitat Ghoshal UC, Chaudhuri S, Pal BB, Dhar K, Ray G, Banerjee PK. Randomized controlled trial of intrasphincteric botulinum toxin A injection versus balloon dilatation in treatment of achalasia cardia. Dis Esophagus. 2001;14:227–31.CrossRefPubMed Ghoshal UC, Chaudhuri S, Pal BB, Dhar K, Ray G, Banerjee PK. Randomized controlled trial of intrasphincteric botulinum toxin A injection versus balloon dilatation in treatment of achalasia cardia. Dis Esophagus. 2001;14:227–31.CrossRefPubMed
9.
Zurück zum Zitat Penagini R, Cantú P, Mangano M, Colombo P, Bianchi PA. Long-term effects of pneumatic dilatation on symptoms and lower oesophageal sphincter pressure in achalasia. Scand J Gastroenterol. 2002;37:380–4.CrossRefPubMed Penagini R, Cantú P, Mangano M, Colombo P, Bianchi PA. Long-term effects of pneumatic dilatation on symptoms and lower oesophageal sphincter pressure in achalasia. Scand J Gastroenterol. 2002;37:380–4.CrossRefPubMed
10.
Zurück zum Zitat Zerbib F, Thétiot V, Richy F, Benajah D-A, Message L, Lamouliatte H. Repeated pneumatic dilations as long-term maintenance therapy for esophageal achalasia. Am J Gastroenterol. 2006;101:692–7.CrossRefPubMed Zerbib F, Thétiot V, Richy F, Benajah D-A, Message L, Lamouliatte H. Repeated pneumatic dilations as long-term maintenance therapy for esophageal achalasia. Am J Gastroenterol. 2006;101:692–7.CrossRefPubMed
11.
Zurück zum Zitat Vela MF, Richter JE, Khandwala F, Blackstone EH, Wachsberger D, Baker ME, et al. The long-term efficacy of pneumatic dilatation and Heller myotomy for the treatment of achalasia. Clin Gastroenterol Hepatol. 2006;4:580–7.CrossRefPubMed Vela MF, Richter JE, Khandwala F, Blackstone EH, Wachsberger D, Baker ME, et al. The long-term efficacy of pneumatic dilatation and Heller myotomy for the treatment of achalasia. Clin Gastroenterol Hepatol. 2006;4:580–7.CrossRefPubMed
12.
Zurück zum Zitat Eckardt VF, Gockel I, Bernhard G. Pneumatic dilation for achalasia: late results of a prospective follow up investigation. Gut. 2004;53:629–33.CrossRefPubMed Eckardt VF, Gockel I, Bernhard G. Pneumatic dilation for achalasia: late results of a prospective follow up investigation. Gut. 2004;53:629–33.CrossRefPubMed
13.
Zurück zum Zitat Farhoomand K, Connor JT, Richter JE, Achkar E, Vaezi MF. Predictors of outcome of pneumatic dilation in achalasia. Clin Gastroenterol Hepatol. 2004;2:384–94.CrossRef Farhoomand K, Connor JT, Richter JE, Achkar E, Vaezi MF. Predictors of outcome of pneumatic dilation in achalasia. Clin Gastroenterol Hepatol. 2004;2:384–94.CrossRef
14.
Zurück zum Zitat Ponce J, Garrigues V, Pertejo V, Sala T, Berenguer J. Individual prediction of response to pneumatic dilation in patients with achalasia. Dig Dis Sci. 1996;41:2135–41.CrossRefPubMed Ponce J, Garrigues V, Pertejo V, Sala T, Berenguer J. Individual prediction of response to pneumatic dilation in patients with achalasia. Dig Dis Sci. 1996;41:2135–41.CrossRefPubMed
15.
Zurück zum Zitat Karamanolis G, Sgouros S, Karatzias G, Papadopoulou E, Vasiliadis K, Stefanidis G, et al. Long-term outcome of pneumatic dilation in the treatment of achalasia. Am J Gastroenterol. 2005;100:270–4.CrossRefPubMed Karamanolis G, Sgouros S, Karatzias G, Papadopoulou E, Vasiliadis K, Stefanidis G, et al. Long-term outcome of pneumatic dilation in the treatment of achalasia. Am J Gastroenterol. 2005;100:270–4.CrossRefPubMed
16.
Zurück zum Zitat Parkman HP, Reynolds JC, Ouyang A, Rosato EF, Eisenberg JM, Cohen S. Pneumatic dilatation or esophagomyotomy treatment for idiopathic achalasia: clinical outcomes and cost analysis. Dig Dis Sci. 1993;38:75–85.CrossRefPubMed Parkman HP, Reynolds JC, Ouyang A, Rosato EF, Eisenberg JM, Cohen S. Pneumatic dilatation or esophagomyotomy treatment for idiopathic achalasia: clinical outcomes and cost analysis. Dig Dis Sci. 1993;38:75–85.CrossRefPubMed
17.
Zurück zum Zitat West RL, Hirsch DP, Bartelsman JF, de Borst J, Ferwerda G, Tytgat GN, et al. Long term results of pneumatic dilation in achalasia followed for more than 5 years. Am J Gastroenterol. 2002;97:1346–51.CrossRefPubMed West RL, Hirsch DP, Bartelsman JF, de Borst J, Ferwerda G, Tytgat GN, et al. Long term results of pneumatic dilation in achalasia followed for more than 5 years. Am J Gastroenterol. 2002;97:1346–51.CrossRefPubMed
18.
Zurück zum Zitat Shoenut JP, Duerksen D, Yaffe CS. A prospective assessment of gastroesophageal reflux before and after treatment of achalasia patients: pneumatic dilation versus transthoracic limited myotomy. Am J Gastroenterol. 1997;92:1109–12.PubMed Shoenut JP, Duerksen D, Yaffe CS. A prospective assessment of gastroesophageal reflux before and after treatment of achalasia patients: pneumatic dilation versus transthoracic limited myotomy. Am J Gastroenterol. 1997;92:1109–12.PubMed
19.
Zurück zum Zitat Patti MG, Arcerito M, Tong J, De Pinto M, de Bellis M, Wang A, et al. Importance of preoperative and postoperative pH monitoring in patients with esophageal achalasia. J Gastrointest Surg. 1997;1:505–10.CrossRefPubMed Patti MG, Arcerito M, Tong J, De Pinto M, de Bellis M, Wang A, et al. Importance of preoperative and postoperative pH monitoring in patients with esophageal achalasia. J Gastrointest Surg. 1997;1:505–10.CrossRefPubMed
Metadaten
Titel
Predictors of a better outcome of pneumatic dilatation in patients with primary achalasia
verfasst von
Yuriko Tanaka
Katsuhiko Iwakiri
Noriyuki Kawami
Hirohito Sano
Mariko Umezawa
Makoto Kotoyori
Yoshio Hoshihara
Tsutomu Nomura
Masao Miyashita
Choitsu Sakamoto
Publikationsdatum
01.02.2010
Verlag
Springer Japan
Erschienen in
Journal of Gastroenterology / Ausgabe 2/2010
Print ISSN: 0944-1174
Elektronische ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-009-0145-4

Weitere Artikel der Ausgabe 2/2010

Journal of Gastroenterology 2/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.